These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 20175762)
1. Increased expression of TDP-43 in the skin of amyotrophic lateral sclerosis. Suzuki M; Mikami H; Watanabe T; Yamano T; Yamazaki T; Nomura M; Yasui K; Ishikawa H; Ono S Acta Neurol Scand; 2010 Nov; 122(5):367-72. PubMed ID: 20175762 [TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of ubiquitin in the skin of sporadic amyotrophic lateral sclerosis. Watanabe T; Okeda Y; Yamano T; Ono S J Neurol Sci; 2010 Nov; 298(1-2):52-6. PubMed ID: 20850799 [TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of increased tumor necrosis factor-α in the skin of patients with amyotrophic lateral sclerosis. Fukazawa H; Tsukie T; Higashida K; Fujikura M; Ono S J Clin Neurosci; 2013 Oct; 20(10):1371-6. PubMed ID: 23850047 [TBL] [Abstract][Full Text] [Related]
4. Abundant FUS-immunoreactive pathology in the skin of sporadic amyotrophic lateral sclerosis. Oketa Y; Higashida K; Fukasawa H; Tsukie T; Ono S Acta Neurol Scand; 2013 Oct; 128(4):257-64. PubMed ID: 23448665 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis. Ishikawa H; Yasui K; Oketa Y; Suzuki M; Ono S J Clin Neurosci; 2012 Apr; 19(4):522-6. PubMed ID: 22321369 [TBL] [Abstract][Full Text] [Related]
6. Expression of hepatocyte growth factor in the skin of amyotrophic lateral sclerosis. Nomura M; Oketa Y; Yasui K; Ishikawa H; Ono S Acta Neurol Scand; 2012 Jun; 125(6):389-97. PubMed ID: 21824113 [TBL] [Abstract][Full Text] [Related]
7. TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Zhang H; Tan CF; Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K Acta Neuropathol; 2008 Jan; 115(1):115-22. PubMed ID: 17786458 [TBL] [Abstract][Full Text] [Related]
8. Increased progranulin in the skin of amyotrophic lateral sclerosis: an immunohistochemical study. Yasui K; Oketa Y; Higashida K; Fukazawa H; Ono S J Neurol Sci; 2011 Oct; 309(1-2):110-4. PubMed ID: 21802097 [TBL] [Abstract][Full Text] [Related]
9. Increased cystatin C immunoreactivity in the skin in amyotrophic lateral sclerosis. Ono S; Shimizu N; Imai T; Mihori A; Nagao K Acta Neurol Scand; 2000 Jul; 102(1):47-52. PubMed ID: 10893063 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies of vascular endothelial growth factor in skin of patients with amyotrophic lateral sclerosis. Suzuki M; Watanabe T; Mikami H; Nomura M; Yamazaki T; Irie T; Ishikawa H; Yasui K; Ono S J Neurol Sci; 2009 Oct; 285(1-2):125-9. PubMed ID: 19592043 [TBL] [Abstract][Full Text] [Related]
11. Sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration: a TDP-43 immunohistochemical study. Miki Y; Mori F; Nunomura J; Ookawa K; Yajima N; Yagihashi S; Wakabayashi K Neuropathology; 2010 Apr; 30(2):149-53. PubMed ID: 19703266 [TBL] [Abstract][Full Text] [Related]
12. TDP-43 Cytoplasmic Translocation in the Skin Fibroblasts of ALS Patients. Rubio MA; Herrando-Grabulosa M; Velasco R; Blasco I; Povedano M; Navarro X Cells; 2022 Jan; 11(2):. PubMed ID: 35053327 [TBL] [Abstract][Full Text] [Related]
13. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564 [TBL] [Abstract][Full Text] [Related]
14. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769 [TBL] [Abstract][Full Text] [Related]
15. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients. Yamashita T; Kwak S Brain Res; 2014 Oct; 1584():28-38. PubMed ID: 24355598 [TBL] [Abstract][Full Text] [Related]
16. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. Sanelli T; Xiao S; Horne P; Bilbao J; Zinman L; Robertson J J Neuropathol Exp Neurol; 2007 Dec; 66(12):1147-53. PubMed ID: 18090923 [TBL] [Abstract][Full Text] [Related]
17. TDP-43 in the skin of amyotrophic lateral sclerosis patients. Abe K; Ohkubo T; Yokota T J Med Dent Sci; 2017; 64(1):9-17. PubMed ID: 28367944 [TBL] [Abstract][Full Text] [Related]
18. Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis. Mori F; Tanji K; Miki Y; Wakabayashi K J Neuropathol Exp Neurol; 2009 Nov; 68(11):1200-6. PubMed ID: 19816197 [TBL] [Abstract][Full Text] [Related]
19. [The implications of TDP-43 mutations in pathogenesis of amyotrophic lateral sclerosis]. Ishihara T; Yokoseki A; Nishizawa M; Takahashi H; Onodera O Brain Nerve; 2009 Nov; 61(11):1301-7. PubMed ID: 19938687 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical studies of angiogenin in the skin of patients with amyotrophic lateral sclerosis. Higashida K; Tsukie T; Fukazawa H; Fujikura M; Ono S J Neurol Sci; 2013 Mar; 326(1-2):18-23. PubMed ID: 23351638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]